U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 10-16, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 10-16, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 05/11/2020
Location: Teleconference
Subject: Association for Accessible Medicines Board of Directors Meeting: COVID-19 Related Activities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Board of Directors for the Association for Accessible Medicine

Event Date: 05/12/2020
Location: Teleconference
Subject: Update on COVID-19 Testing
FDA Participant/Group: ANAND SHAH; KEAGAN LENIHAN;
Non FDA Participant/Group: Gianrico Farrugia (Mayo Clinic);

Event Date: 05/13/2020
Location: Teleconference
Subject: COVID-19 Diagnostics
FDA Participant/Group: ANAND SHAH; KEAGAN LENIHAN; COLIN ROM;
Non FDA Participant/Group: Mark Stevenson (Thermo Fisher Scientific);

Event Date: 05/14/2020
Location: Teleconference
Subject: COVID-19 Diagnostics
FDA Participant/Group: JEFFREY SHUREN; KEAGAN LENIHAN; ANAND SHAH;
Non FDA Participant/Group: Government and several Thermo Fisher Scientific staff

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 05/11/2020
Location: Virtual
Subject: World Medical Innovation Forum - FDA Role in Managing the Crisis and Anticipating the Next
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academics, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 05/12/2020
Location: Teleconference
Subject: COVID-19 Therapies and Vaccine
FDA Participant/Group: GURJEET GURAM; ANAND SHAH; LOWELL ZETA;
Non FDA Participant/Group: Dianna Dunne (Milken Institute);

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/14/2020
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA leaders and staff
Non FDA Participant/Group: Representatives from consumer, trade union, and foodborne illness victim organizations

Event Date: 05/14/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives from the food and beverage industry

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/12/2020
Location: Virtual Webinar
Subject: Gene Therapy in NF (Neurofibromitosis) Webinar: Opportunities and Challenges in Gene Therapy for Neurofibromatosis
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, patient groups, and government

Event Date: 05/12/2020
Location: Virtual Webinar
Subject: American Society of Hematology (ASH) Webinar: The Use of Convalescent Plasma During COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, patient groups, and government

Event Date: 05/13/2020
Location: Virtual Webinar
Subject: Duke-Margolis/Alexandria Summit Webinar: Developing and Scaling COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, patient groups, and government

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event